Evidence map›Paper›PMID 39334340›Full record

ArticleBMC health services research2024

Assessing the reliability and readability of migraine treatment information on Turkish websites.

Tuba Tanyel Saraçoğlu, Gizem Gürsoy

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tuba Tanyel SaraçoğluPain Management Clinic, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye. tbtnyl@gmail.com.
Gizem GürsoyNeurology Clinic, Ümraniye Research and Training Hospital, İstanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe quality and safety of information provided on online platforms for migraine treatment remains uncertain. We evaluated the top 10 trending websites accessed annually by Turkish patients seeking solutions for migraine treatment and assessed information quality, security, and readability in this cross-sectional study.

methodsA comprehensive search strategy was conducted using Google starting in 2015, considering Türkiye's internet usage trends. Websites were evaluated using the DISCERN measurement tool and Ateşman Turkish readability index.

resultsNinety websites were evaluated between 2015 and 2024. According to the DISCERN measurement tool, most websites exhibited low quality and security levels. Readability analysis showed that half of the websites were understandable by readers with 9th - 10th grade educational levels. The author distribution varied, with neurologists being the most common. A significant proportion of the websites were for profit. Treatment of attacks and preventive measures were frequently mentioned, but some important treatments, such as greater occipital nerve blockade, were rarely discussed.

conclusionThis study highlights the low quality and reliability of online information websites on migraine treatment in Türkiye. These websites' readability level remains a concern, potentially hindering patients' access to accurate information. This can be a barrier to migraine care for both patients with migraine and the physician. Better supervision and cooperation with reputable medical associations are needed to ensure the dissemination of reliable information to the public.

Indexed as

ComprehensionConsumer Health InformationInternetMigraine DisordersCross-Sectional StudiesHealth LiteracyHumansReproducibility of ResultsTurkeyDiscern measurement toolMigraineReadability indexTürkiye

Identifiers

PMID39334340
PMCPMC11430538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.